Listed by the USPTO as JANG, CHRISTIAN Y
Tech Center 3700 • Art Units: 3735 3791 3792
This examiner grants 69% of resolved cases
JANG, CHRISTIAN Y examines in tech center 3700 and art unit 3735. The profile records 862 resolved cases, a 68.7% allowance rate, and a median of 1384 days to allowance. The 21.0% interview lift indicates that interview-linked outcomes differ from the profile's overall allowance result. For applicants, the figures point to the need for deliberate prosecution planning, particularly where claim scope and examination duration affect filing strategy.
The principal companies are Abbott Laboratories, DexCom Inc., and The Regents of the University of California. The listed firms are One LLP - ADC, PATTERSON + SHERIDAN, L.L.P. - Dexcom, and STERNE, KESSLER, GOLDSTEIN & FOX P.L.L.C. Their records offer useful sources for studying medical-device arguments, amendment choices, and interview practice in art unit 3735.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18568253 | Respiration Detection | Non-Final OA | Apple Inc. |
| 19015978 | ALARM CHARACTERIZATION FOR ANALYTE MONITORING DEVICES AND SYSTEMS | Non-Final OA | ABBOTT DIABETES CARE INC. |
| 18749352 | ANALYTE SENSORS COMPRISING LEVELING AGENTS | Non-Final OA | ABBOTT DIABETES CARE INC. |
| 18674252 | CONTINUOUS ANALYTE MEASUREMENT SYSTEMS AND SYSTEMS AND METHODS FOR IMPLANTING THEM | Non-Final OA | ABBOTT DIABETES CARE INC. |
| 18652924 | SENSITIVITY CALIBRATION OF IN VIVO SENSORS USED TO MEASURE ANALYTE CONCENTRATION | Non-Final OA | Abbott Diabetes Care Inc. |
| 18512733 | METHOD AND SYSTEM FOR PROVIDING CONTINUOUS CALIBRATION OF IMPLANTABLE ANALYTE SENSORS | Final Rejection | ABBOTT DIABETES CARE INC. |
| 18511003 | SYSTEMS, DEVICES, AND METHODS RELATING TO MEDICATION DOSE GUIDANCE | Final Rejection | ABBOTT DIABETES CARE INC. |
| 18055057 | ANALYTE SENSORS FOR SENSING GLUTAMATE AND METHODS OF USING THE SAME | Non-Final OA | Abbott Diabetes Care Inc. |
| 18054442 | METHOD AND SYSTEM FOR PROVIDING BASAL PROFILE MODIFICATION IN ANALYTE MONITORING AND MANAGEMENT SYSTEMS | Non-Final OA | Abbott Diabetes Care Inc. |
| 19059139 | Calibration Free In-Vivo Measurement of Analytes Using Electrochemical Sensors | Non-Final OA | The Regents of the University of California |
| 18835075 | BOWEL TRACKER SYSTEM FOR PASSIVE MONITORING OF BOWEL HABITS | Non-Final OA | The Regents of The University of California |
| 18002995 | System and Method for Detection of Biomolecules in Tissues, Organs, and Extracellular Fluid | Final Rejection | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA |
| 18745010 | Human Gait parameter and Health Information Extraction using Floor-Mounted Geophone Sensors | Final Rejection | The Board of Trustees of the Leland Stanford Junior University |
| 18626915 | RESPIRATION PROCESSOR | Non-Final OA | MASIMO CORPORATION |
| 18781805 | SYSTEMS AND METHODS FOR DISPLAY DEVICE AND SENSOR ELECTRONICS UNIT COMMUNICATION | Non-Final OA | Dexcom, Inc. |
| 18744421 | SYSTEMS AND METHODS FOR PROCESSING AND TRANSMITTING SENSOR DATA | Non-Final OA | Dexcom, Inc. |
| 18740396 | FAULT DISCRIMINATION AND RESPONSIVE PROCESSING BASED ON DATA AND CONTEXT | Non-Final OA | Dexcom, Inc. |
| 18652491 | MEMBRANE FOR CONTINUOUS ANALYTE SENSORS | Non-Final OA | DexCom, Inc. |
| 18592440 | PARTICLE-CONTAINING MEMBRANE AND PARTICULATE ELECTRODE FOR ANALYTE SENSORS | Non-Final OA | DexCom, Inc. |
| 18306074 | USER INTERFACES FOR CONTINUOUS GLUCOSE MONITORING | Final Rejection | Dexcom, Inc. |
| 17096565 | ADAPTIVE DURATION OF INSULIN ACTION FOR USE IN INSULIN ON BOARD CALCULATIONS | Non-Final OA | INSULET CORPORATION |
| 18526209 | RETROSPECTIVE SMOOTHING | Non-Final OA | Senseonics, Incorporated |
| 17800219 | HIGH RELIABILITY ANALYTE DETECTION DEVICE | Non-Final OA | MEDTRUM TECHNOLOGIES INC. |
| 18180635 | APPARATUS AND METHOD FOR ANALYZING IN VIVO COMPONENT AND IMPEDANCE MEASURING APPARATUS | Non-Final OA | GWANGJU INSTITUTE OF SCIENCE AND TECHNOLOGY |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy68.7% of resolved applications examined by Christian Y Jang were allowed (862 resolved cases), compared with 38.6% across Art Unit 3735 over the last five years.
This examiner's interview lift is +21.0 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Christian Y Jang took 1,384 days on average from filing to allowance.
Christian Y Jang examines applications in Art Unit 3735 in Tech Center 3700 (Medical Devices & Mechanical Engineering).
